No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs560634629 |
chr4:44964485-44964486 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs116651880 |
chr4:44964502-44964503 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs145423734 |
chr4:44964558-44964559 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs9291257 |
chr4:44964574-44964575 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs369599534 |
chr4:44964586-44964587 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs28415060 |
chr4:44964602-44964603 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs35186827 |
chr4:44964624-44964625 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs550963136 |
chr4:44964648-44964649 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs28396281 |
chr4:44964660-44964661 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs558405528 |
chr4:44964686-44964687 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs148068965 |
chr4:44964687-44964688 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs576852593 |
chr4:44964693-44964694 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs566964748 |
chr4:44964731-44964732 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs28419289 |
chr4:44964732-44964733 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs552087118 |
chr4:44964763-44964764 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs373199811 |
chr4:44964768-44964769 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs140877022 |
chr4:44964795-44964796 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs577880297 |
chr4:44964833-44964834 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs538851472 |
chr4:44964865-44964866 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs574085493 |
chr4:44964866-44964867 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs556955600 |
chr4:44964869-44964870 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs541486813 |
chr4:44964895-44964896 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs183248969 |
chr4:44964899-44964900 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs559625328 |
chr4:44964926-44964927 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs1908807 |
chr4:44964929-44964930 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
26 |
rs150414409 |
chr4:44964942-44964943 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs1908806 |
chr4:44964953-44964954 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs540489898 |
chr4:44964977-44964978 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs188811499 |
chr4:44964993-44964994 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs539906761 |
chr4:44965001-44965002 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs564031216 |
chr4:44965009-44965010 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs564659893 |
chr4:44965018-44965019 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs138147764 |
chr4:44965022-44965023 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs75266349 |
chr4:44965032-44965033 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs563028672 |
chr4:44965159-44965160 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs530468211 |
chr4:44965193-44965194 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs531463137 |
chr4:44965216-44965217 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs143793793 |
chr4:44965251-44965252 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs535930297 |
chr4:44965265-44965266 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs556144546 |
chr4:44965281-44965282 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs146579692 |
chr4:44965282-44965283 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs191658958 |
chr4:44965303-44965304 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs1390925 |
chr4:44965317-44965318 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs73244689 |
chr4:44965336-44965337 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs139110429 |
chr4:44965459-44965460 |
ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs547450641 |
chr4:44965507-44965508 |
ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs557162124 |
chr4:44965508-44965509 |
ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs565664081 |
chr4:44965511-44965512 |
ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs1390924 |
chr4:44965514-44965515 |
ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs536500025 |
chr4:44965518-44965519 |
ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|